These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26915717)

  • 1. Characterization of five associations of F8 missense mutations containing FVIII B domain mutations.
    Jourdy Y; Nougier C; Roualdes O; Fretigny M; Durand B; Negrier C; Vinciguerra C
    Haemophilia; 2016 Jul; 22(4):583-9. PubMed ID: 26915717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of F8 B domain gene variants on synthesis, secretion, activity and stability of factor VIII protein.
    Pahl S; Pavlova A; Driesen J; Oldenburg J
    Thromb Haemost; 2014 Jan; 111(1):58-66. PubMed ID: 24108539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency.
    Roualdes O; Nougier C; Fretigny M; Talagrand E; Durand B; Negrier C; Vinciguerra C
    Haemophilia; 2015 May; 21(3):e202-e209. PubMed ID: 25708597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping.
    Ogata K; Selvaraj SR; Miao HZ; Pipe SW
    J Thromb Haemost; 2011 Jun; 9(6):1183-90. PubMed ID: 21645226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
    Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
    Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico analyses of missense mutations in coagulation factor VIII: identification of severity determinants of haemophilia A.
    Sengupta M; Sarkar D; Ganguly K; Sengupta D; Bhaskar S; Ray K
    Haemophilia; 2015 Sep; 21(5):662-9. PubMed ID: 25854144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
    Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.
    Wei W; Zheng C; Zhu M; Zhu X; Yang R; Misra S; Zhang B
    Sci Rep; 2017 Mar; 7():45033. PubMed ID: 28327546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
    Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
    J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies.
    Pezeshkpoor B; Gazorpak M; Berkemeier AC; Singer H; Pavlova A; Biswas A; Oldenburg J
    Ann Hematol; 2019 Aug; 98(8):1855-1865. PubMed ID: 30997536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII C2 domain missense mutations exhibit defective trafficking of biologically functional proteins.
    Pipe SW; Kaufman RJ
    J Biol Chem; 1996 Oct; 271(41):25671-6. PubMed ID: 8810344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of F8 defects in haemophilia A in Pakistan: investigation of correlation between mutation type and the in vitro thrombin generation assay.
    Khanum F; Collins PW; Harris RL; Bowen DJ
    Haemophilia; 2014 Mar; 20(2):287-93. PubMed ID: 24118398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression studies of mutant factor VIII alleles with premature termination codons with regard to inhibitor formation.
    Zimmermann MA; Oldenburg J; Müller CR; Rost S
    Haemophilia; 2014 May; 20(3):e215-21. PubMed ID: 24602271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions.
    Jayandharan G; Shaji RV; Baidya S; Nair SC; Chandy M; Srivastava A
    Haemophilia; 2005 Sep; 11(5):481-91. PubMed ID: 16128892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of four novel molecular changes in the promoter region of the factor VIII gene.
    Nougier C; Roualdes O; Fretigny M; d'Oiron R; Costa C; Negrier C; Vinciguerra C
    Haemophilia; 2014 Mar; 20(2):e149-56. PubMed ID: 24372689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.
    Amano K; Sarkar R; Pemberton S; Kemball-Cook G; Kazazian HH; Kaufman RJ
    Blood; 1998 Jan; 91(2):538-48. PubMed ID: 9427707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustered
    Donadon I; McVey JH; Garagiola I; Branchini A; Mortarino M; Peyvandi F; Bernardi F; Pinotti M
    Haematologica; 2018 Feb; 103(2):344-350. PubMed ID: 29170251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular analysis of a patient with hemophilia A caused by FVIII His99Arg mutation].
    Qin HH; Wang XF; Ding QL; Lu YL; Dai J; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):587-91. PubMed ID: 22338150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).
    David D; Saenko EL; Santos IM; Johnson DJ; Tuddenham EG; McVey JH; Kemball-Cook G
    Br J Haematol; 2001 Jun; 113(3):604-15. PubMed ID: 11380445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of pathogenicity of a mutation in 3' untranslated region causing mild haemophilia A.
    Pezeshkpoor B; Berkemeier AC; Czogalla KJ; Oldenburg J; El-Maarri O
    Haemophilia; 2016 Jul; 22(4):598-603. PubMed ID: 27216882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.